β-1,3-Gal-T2 Polyclonal Antibody

货号：ES7863
价格：面议
点击：2004

产品介绍

抗体信息

应用	IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse
别称	B3GALT2; Beta-1; 3-galactosyltransferase 2; Beta-1,3-GalTase 2; Beta3Gal-T2; Beta3GalT2; UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	314
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	428
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	277
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	405
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	265
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	366
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	136
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	211
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	149
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	360
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	444
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	274
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	289
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	443
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	505
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	285
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	142
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	481
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	354
Anti-Certolizumab Neutralizing Recombinant Antibody \|抗赛妥珠单抗中和重组抗体(靶标：赛妥珠单抗中和抗体)	152

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00